Showing 1,101 - 1,120 results of 116,717 for search '(( a non decrease ) OR ( 5 ((wt decrease) OR (((we decrease) OR (a decrease)))) ))', query time: 1.67s Refine Results
  1. 1101
  2. 1102
  3. 1103
  4. 1104
  5. 1105
  6. 1106

    Effectiveness and Limitations of Hand Hygiene Promotion on Decreasing Healthcare–Associated Infections by Yee-Chun Chen (103279)

    Published 2011
    “…The disease severity score (Charlson comorbidity index) increased (<em>p</em> = .002) during the intervention period. Nevertheless, we observed an 8.9% decrease in HAIs and a decline in the occurrence of bloodstream, methicillin-resistant <em>Staphylococcus aureus</em>, extensively drug-resistant <em>Acinetobacter baumannii</em>, and intensive care unit infections. …”
  7. 1107
  8. 1108

    IgG-mediated systemic anaphylaxis decreased in BasoDTR mice. by Kunie Matsuoka (400418)

    Published 2013
    “…<p>(A) BasoDTR mice (n = 4 per group) were treated once i.p. with 25 or 50 µg/kg of DT or PBS at 4 days prior to and were i.v. injected with 500 µg rat anti-FcγRII/III (2.4G2) antibodies in 200 µl PBS. …”
  9. 1109
  10. 1110
  11. 1111

    Decreased IL-7 Responsiveness Is Related to Oxidative Stress in HIV Disease by Magdalina Kalinowska (386552)

    Published 2013
    “…To explore mechanisms of these deficiencies, we compared CD127 expression and IL-7 induction of P-STAT5 in T cells from HIV-infected persons with serum concentrations of cytokines (IL-7, IL-6 and IL-15), markers of microbial translocation (sCD14 and LPS), and with an indicator of oxidative stress (malondialdehyde (MDA) adducts). …”
  12. 1112
  13. 1113
  14. 1114
  15. 1115
  16. 1116
  17. 1117

    Image_1_IL-6 Receptor Inhibition by Tocilizumab Attenuated Expression of C5a Receptor 1 and 2 in Non-ST-Elevation Myocardial Infarction.TIF by Hilde L. Orrem (5740313)

    Published 2018
    “…</p><p>Results: Our main findings were (i) Tocilizumab decreased C5aR1 and C5aR2 mRNA expression significantly (p < 0.001) and substantially (>50%) at day 2 and 3, whereas C3aR expression was unaffected. …”
  18. 1118

    Image_2_IL-6 Receptor Inhibition by Tocilizumab Attenuated Expression of C5a Receptor 1 and 2 in Non-ST-Elevation Myocardial Infarction.TIF by Hilde L. Orrem (5740313)

    Published 2018
    “…</p><p>Results: Our main findings were (i) Tocilizumab decreased C5aR1 and C5aR2 mRNA expression significantly (p < 0.001) and substantially (>50%) at day 2 and 3, whereas C3aR expression was unaffected. …”
  19. 1119

    Table_1_IL-6 Receptor Inhibition by Tocilizumab Attenuated Expression of C5a Receptor 1 and 2 in Non-ST-Elevation Myocardial Infarction.DOCX by Hilde L. Orrem (5740313)

    Published 2018
    “…</p><p>Results: Our main findings were (i) Tocilizumab decreased C5aR1 and C5aR2 mRNA expression significantly (p < 0.001) and substantially (>50%) at day 2 and 3, whereas C3aR expression was unaffected. …”
  20. 1120